Novo Nordisk inks pact for discovery of 'molecular glues' in deal worth as much as $1.46B
Novo Nordisk has inked an up to $1.46 billion deal with the biotech Neomorph to develop “molecular glues,” a field that’s seeing a flurry of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
